Modern Dental Group (3600) H1 2024 earnings summary

Executive summary

• Revenue for 1H2024 grew 6.3% year-over-year to HK$1,702 million, driven by higher sales volume, market share gains, and digital solutions, especially in Europe and Australia.

• Net profit rose 1.9% year-over-year to HK$214.4 million, with adjusted EBITDA up 5.1% to HK$389 million, reflecting solid operational execution despite macroeconomic challenges.

• Interim dividend increased to HK8.0 cents per share, up from HK6.0 cents last year, with a payout ratio of approximately 35%.

• Leveraged a vertically integrated business model and global distribution network, serving over 30,000 dentists in 23+ countries.

• Accelerated digital transformation, with intraoral scanner cases showing a 45.1% two-year CAGR and TrioClear clear aligner revenue up 45.5% year-over-year.

Financial highlights

• Gross profit margin was 53.7%, slightly down year-over-year due to currency depreciation and volume-based procurement in China.

• Adjusted EBITDA margin at 22.8%; basic earnings per share increased to HK22.59 cents.

• Cash and cash equivalents stood at HK$692 million as of 30 June 2024; net cash from operating activities was HK$210.8 million.

• Capital expenditure reached HK$98.1 million, mainly for production expansion and equipment upgrades.

• Dividend payout increased 33.3% year-over-year.

Outlook and guidance

• Expects continued strong global demand for dental prosthetics, driven by aging populations and increased oral health awareness.

• Plans to diversify product portfolio, expand digital solutions, and pursue further market consolidation through acquisitions and partnerships.

• Focus on leveraging digital dentistry trends and expanding in Europe, North America, and Greater China.

• Investments in new production facilities in Dongguan and Vietnam are expected to enhance production capacity and R&D.